Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Carboplatin × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 42 Lymphoma 34 Lymphoma, Non-Hodgkin 25 Hodgkin Disease 20 Lymphoma, Follicular 16 Burkitt Lymphoma 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, Large-Cell, Anaplastic 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, B-Cell, Marginal Zone 11 Lymphoma, B-Cell 9 Immunoblastic Lymphadenopathy 8 Leukemia, Myeloid, Acute 7 Blast Crisis 7 Waldenstrom Macroglobulinemia 6 Recurrence 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Accelerated Phase 6 Leukemia 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Mycosis Fungoides 5 Leukemia, Myeloid, Chronic-Phase 5 Dendritic Cell Sarcoma, Interdigitating 5 Sezary Syndrome 4 Neoplasms 4 Myelodysplastic Syndromes 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, T-Cell, Cutaneous 4

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡